Yvonne D. Krom
Leiden, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Effects of intermittent corticosteroids on scoliosis, bone density, and vertebral fractures in duchenne muscular dystrophy.
Journal: Journal of neuromuscular diseases
Published: July 24, 2026
Balancing Benefits and Risks: Long-term Use of Daily versus Intermittent Corticosteroids in Duchenne Muscular Dystrophy.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: April 02, 2026
Longitudinal ankle range of motion and functional decline in Duchenne muscular dystrophy.
Journal: Neuromuscular disorders : NMD
Published: September 04, 2025
The Dutch Dystrophinopathy Database: A National Registry with Standardized Patient and Clinician Reported Real-World Data.
Journal: Journal of neuromuscular diseases
Published: July 20, 2024
The Dilemma of Choice for Duchenne Patients Eligible for Exon 51 Skipping The European Experience.
Journal: Journal of neuromuscular diseases
Published: March 13, 2023
T Cell Responses to Dystrophin in a Natural History Study of Duchenne Muscular Dystrophy.
Journal: Human gene therapy
Published: December 01, 2022
Compliance to DMD Care Considerations in the Netherlands.
Journal: Journal of neuromuscular diseases
Published: June 14, 2021
SMCHD1 has separable roles in chromatin architecture and gene silencing that could be targeted in disease.
Journal: Nature communications
Published: May 10, 2021
Decision-Making And Selection Bias in Four Observational Studies on Duchenne and Becker Muscular Dystrophy.
Journal: Journal of neuromuscular diseases
Published: September 14, 2020
Dnmt3b regulates DUX4 expression in a tissue-dependent manner in transgenic D4Z4 mice.
Journal: Skeletal muscle
Published: May 07, 2020
Last Updated: 09/26/2026